Surgery Partners, Inc. (NASDAQ:SGRY) Receives $39.86 Average Target Price from Analysts

Shares of Surgery Partners, Inc. (NASDAQ:SGRY) have been assigned an average rating of “Moderate Buy” from the seven research firms that are currently covering the stock, Marketbeat reports. One analyst has rated the stock with a hold rating and six have assigned a buy rating to the company. The average 12 month target price among analysts that have issued ratings on the stock in the last year is $39.86.

Several equities research analysts have recently weighed in on the stock. Royal Bank of Canada reiterated an “outperform” rating and set a $49.00 target price on shares of Surgery Partners in a research note on Wednesday, August 7th. Citigroup dropped their target price on Surgery Partners from $38.00 to $36.00 and set a “buy” rating on the stock in a report on Wednesday, August 7th. Macquarie began coverage on Surgery Partners in a report on Friday, June 28th. They set an “outperform” rating and a $31.00 price target for the company. StockNews.com cut shares of Surgery Partners from a “hold” rating to a “sell” rating in a research note on Wednesday, August 7th. Finally, Benchmark restated a “buy” rating and issued a $50.00 target price on shares of Surgery Partners in a research note on Wednesday, August 7th.

Insider Buying and Selling

In other news, insider Danielle Burkhalter sold 6,000 shares of Surgery Partners stock in a transaction that occurred on Wednesday, June 12th. The shares were sold at an average price of $26.39, for a total transaction of $158,340.00. Following the sale, the insider now owns 30,354 shares in the company, valued at $801,042.06. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 2.30% of the stock is currently owned by company insiders.

Institutional Trading of Surgery Partners

Hedge funds have recently made changes to their positions in the stock. Arizona State Retirement System grew its position in shares of Surgery Partners by 1.9% in the 2nd quarter. Arizona State Retirement System now owns 19,494 shares of the company’s stock worth $464,000 after acquiring an additional 359 shares in the last quarter. Mesirow Institutional Investment Management Inc. boosted its holdings in Surgery Partners by 12.4% in the fourth quarter. Mesirow Institutional Investment Management Inc. now owns 3,388 shares of the company’s stock worth $108,000 after purchasing an additional 373 shares during the period. Natixis Advisors L.P. increased its stake in Surgery Partners by 8.6% during the fourth quarter. Natixis Advisors L.P. now owns 11,735 shares of the company’s stock valued at $375,000 after purchasing an additional 934 shares during the last quarter. ProShare Advisors LLC increased its stake in Surgery Partners by 7.8% during the first quarter. ProShare Advisors LLC now owns 13,588 shares of the company’s stock valued at $405,000 after purchasing an additional 986 shares during the last quarter. Finally, Natixis Advisors LLC lifted its position in shares of Surgery Partners by 11.0% in the 2nd quarter. Natixis Advisors LLC now owns 12,452 shares of the company’s stock worth $296,000 after buying an additional 1,237 shares during the last quarter.

Surgery Partners Trading Up 3.1 %

SGRY opened at $30.00 on Friday. The business’s 50-day simple moving average is $26.64 and its 200-day simple moving average is $27.86. The company has a market cap of $3.81 billion, a P/E ratio of 41.89, a PEG ratio of 1.73 and a beta of 2.78. Surgery Partners has a one year low of $22.05 and a one year high of $37.83. The company has a debt-to-equity ratio of 0.96, a quick ratio of 1.69 and a current ratio of 1.83.

Surgery Partners (NASDAQ:SGRY) last posted its earnings results on Tuesday, August 6th. The company reported $0.21 EPS for the quarter, beating analysts’ consensus estimates of $0.20 by $0.01. The firm had revenue of $762.10 million for the quarter, compared to the consensus estimate of $735.94 million. Surgery Partners had a negative net margin of 1.17% and a positive return on equity of 2.96%. The company’s revenue was up 14.2% on a year-over-year basis. During the same period last year, the firm posted $0.25 EPS. As a group, equities research analysts expect that Surgery Partners will post 0.88 EPS for the current fiscal year.

Surgery Partners Company Profile

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.